The statement leaves the proposed funding as an unconfirmed plan rather than an established transaction.
Slight Ache LLC lists a $1,500,000 ($1.5 million) exempt offering of LLC membership interests designated as Class A Units, with the full amount sold and $0 remaining. The amended record identifies a $25,000 minimum investment. The offering is tied to a New YorkLimited Liabilitycompany.
Purchase Recorded at $27.15 Per Share
SMITH MIDLAND CORP Chief Executive Officer SMITH ASHLEY B purchased 2,000 shares at $26.87 per share on Sep 1, 2026.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) saw Chief Tech Operations Officer Horan Christopher sell 10,366 shares at $11.16 per share. The transaction was dated September 3, 2026.
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) Chief Medical Officer Banerjee Subhashis sold 1,100 shares at $11.16 per share. The transaction was dated Sep. 3, 2026, and following it he owned 140,947 shares.
ASP Isotopes Inc. (NASDAQ: ASPI) COO Ainscow Robert sold 25,000 shares at $3.90 per share. The transaction took place on September 2, 2026.
Azenta, Inc. (NASDAQ: AZTA) received $35 million in full repayment of a secured vendor loan before maturity.
Butterfly Network, Inc. (NYSE: BFLY) recorded the sale of 1,709 shares by Deputy General Counsel Caezza Nicholas at $8.15 per share. The transaction took place on Sep. 2, 2026.
Caris Life Sciences, Inc. (NASDAQ: CAI) President Spetzler David Baxley exercised options for 1,250,000 shares at $2.44 per share. The transactions were dated September 3 and September 4, with Baxley’s holdings reaching 1,302,083 shares after the exercises.